[Correspondence] Mycoplasma pneumoniae: re-emergence and beyond

The re-emergence of Mycoplasma pneumoniae in late 2023 placed a considerable burden on health-care systems and raised concerns regarding the severity of pneumonia outbreaks.1 The European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) Mycoplasma pneumoniae surveillance (MAPS) study2 was able to attribute these outbreaks to M pneumoniae and found no statistically significant global increase in the proportion of severe outcomes compared with that of pre-pandemic epidemics.